NA

NewAmsterdam Pharma Company NVNASDAQ NAMS Stock Report

Last reporting period 31 Dec, 2022

Updated 18 Nov, 2024

Last price

Market cap $B

0.174

Micro

Exchange

XNAS - Nasdaq

View Section: Company Analysis

NewAmsterdam Pharma Rating

NA

NAMS stock is not rated by Eyestock analysis.

The financial statements data is not enough to calculate the rating

Discover High-rated Companies


View Section: Valuation